ScopeMedizinische Hochschule Hannover Institut für Humangenetik
18 capabilities
Accredited since July 2025
Verified Apr 2026
One of 3,039 in Germany
Details
Carl-Neuberg-Straße 1
Hannover 30625 , Germany
Hannover 30625 , Germany
Accreditation
Active
DAkkS
D-ML-13168-01-00
Specialises in molecular human genetics and cytogenetics testing with flexible accreditation for method development and modification. Performs molecular biology examinations including next-generation sequencing panels and nested PCR on blood and bone marrow samples for diagnostics such as acute myeloid leukaemia prognostication.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-13168-01-00
Status
ActiveSince
02 July 2025
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDFSend an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.
Test Capabilities (18)
| Standard Reference | Description | Category |
|---|---|---|
| Angeborener Chromosomensatz | angeborener Chromosomensatz | Biocompatibility (ISO 10993) |
| Erworbener Chromosomensatz | erworbener Chromosomensatz | Biocompatibility (ISO 10993) |
| (CML): BCR/ABL t(9;22) | myeloische Leukämie (CML) | Molecular Diagnostics / PCR |
| Chronische myeloische Leukämie | Chronische myeloische Leukämie: | Molecular Diagnostics / PCR |
| (Erweitertes-Panel): ASXL2, BCOR, BRAF, CBL, CDKN2A, CUX1, ETV6, EZH2, GATA1, GATA2, GNAS, IKZF1, NF1, PHF6, PTPN11, RAD21, SF3B1, SMC1A, SCM3, SF3B1, SRSF2, STAG2, U2AF1, WT1, ZRSR2 | (Erweitertes-Panel): ASXL2, BCOR, BRAF, CBL, CDKN2A, CUX1, ETV6, EZH2, GATA1, GATA2, GNAS, IKZF1, NF1, PHF6, PTPN11, RAD21, SF3B1, SMC1A, SCM3, SF3B1, SRSF2, STAG2, U2AF1, WT1, ZRSR2 | Sterility Testing |
| (FLCN) | Birt-Hogg-Dubé-Syndrom (FLCN) | Sterility Testing |
| (Prognose- und Therapie-Panel): | (Prognose- und Therapie-Panel): | Sterility Testing |
| (RPL5, RPL8, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26) | (RPL5, RPL8, RPL11, RPL35A, RPS10, RPS17, RPS19, RPS24, RPS26) | Sterility Testing |
| AML1/ETO t(8;21), PML/RARA | AML1/ETO t(8;21), PML/RARA | Sterility Testing |
| ASXL1, CEBPA, CKIT, DNMT3A, FLT3, IDH1, IDH2, KRAS, NPM1, NRAS, RUNX1, TET2, TP53 und | ASXL1, CEBPA, CKIT, DNMT3A, FLT3, IDH1, IDH2, KRAS, NPM1, NRAS, RUNX1, TET2, TP53 und | Sterility Testing |
| Akute myeloische Leukämie (AML) | Akute myeloische Leukämie (AML) | Sterility Testing |
| Blackfan-Diamond-Anämie | Blackfan-Diamond-Anämie | Sterility Testing |
| Myelofibrose (PMF): JAK2 V617F | Myelofibrose (PMF): JAK2 V617F | Sterility Testing |
| Nachweis von Fusionsgenen | Nachweis von Fusionsgenen | Sterility Testing |
| Polyzythämie vera (PV)/ Essentielle | Polyzythämie vera (PV)/ Essentielle | Sterility Testing |
| Thrombozythämie (ET)/ Primäre | Thrombozythämie (ET)/ Primäre | Sterility Testing |
| duplikationen und CN-LOHs | duplikationen und CN-LOHs | Sterility Testing |
| inv(16) | t(15;17), BFB/MYH 11inv(16) | Sterility Testing |